Airain Ltd’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Airain Ltd’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-97,990	Closed	-$2.12M	–	1180
2015 Q4	$2.12M	Buy	+97,990	New	+$1.91M	0.15%	184
2014 Q4	–	Sell	-12,228	Closed	-$150K	–	1006
2014 Q3	$150K	Sell	12,228 -52,078	-81%	-$605K	0.01%	704
2014 Q2	$1.02M	Buy	+64,306	New	+$918K	0.08%	261

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Airain Ltd's HZNP Position: Q1 2016 in Review

Airain Ltd sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2016, closing a stake of 97,990 shares — an estimated $2.12M sold.

Airain Ltd first reported a position in HZNP in Q2 2014 and held it in 3 quarters. The position peaked at $2.12M in Q4 2015. 196 funds tracked by Wall St. Rank hold HZNP as of Q1 2016.

Airain Ltd reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2016 after selling out during the quarter.
Airain Ltd sold 97,990 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2016, an estimated $2.12M.
Airain Ltd first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2014 and held it in 3 quarters.
Airain Ltd's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.12M in Q4 2015.
196 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2016.

Based on Airain Ltd's 13F filing for Q1 2016, filed 9 May 2016.